lenzumestrocel

Cell therapyexperimental

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Mar 23, 2021 (NCT04745299)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06676423Phase 1Nov 9, 2022Corestem, Inc., Hanyang University
NCT04745299Phase 3Mar 23, 2021Corestem, Inc., Hanyang University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Corestem, Inc.For profit2222021
Hanyang UniversityAcademic/Hospital2022021
2 organizations
Page 1 / 1